Patents for C07K 19 - Hybrid peptides (29,428) |
---|
10/09/2008 | US20080248057 Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation |
10/09/2008 | US20080248031 Cell surface molecule mediating cell adhesion and signal transmission |
10/09/2008 | CA2682227A1 Insecticidal proteins |
10/09/2008 | CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants |
10/08/2008 | EP1978036A1 A mycobacterium tuberculosis fusion protein and uses thereof |
10/08/2008 | EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
10/08/2008 | EP1976992A1 Methods and compositions for the detection and isolation of ligands |
10/08/2008 | EP1976876A1 Process for the production of preformed conjugates of albumin and a therapeutic agent |
10/08/2008 | EP1863850A4 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
10/08/2008 | EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer |
10/08/2008 | EP1071779B1 Vertebrate patched-2 protein |
10/08/2008 | EP0752005B1 Compacted nucleic acids and their delivery to cells |
10/08/2008 | CN101280022A Fused protein of D-aminoacid oxidase, carrier and application thereof |
10/08/2008 | CN101280021A Engineered protein against shrimp white spot syndrome virus, preparation and use thereof |
10/08/2008 | CN101280020A Fused protein of human serum albumin and human insulin C-peptide, and preparation thereof |
10/08/2008 | CN101280019A Fused protein of human serum albumin and human granulocyte colony stimulating factor mutant, and preparation thereof |
10/08/2008 | CN101280018A Fused protein of mutant human interleukin-2 and human serum albumin, and preparation thereof |
10/08/2008 | CN101280017A Fused protein of human brain natriuretic peptide diad [(BNP)2] and human serum albumin (HAS), and preparation thereof |
10/08/2008 | CN100424096C Survivin mutant containing HIV transduction structural area and its preparation method and uses |
10/08/2008 | CN100424095C Recombinant targeted toxin against HIV-1 |
10/07/2008 | US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
10/07/2008 | US7432348 Novel Protein Histidine Phosphatase Interacting Partner of 180 KD; polypeptides/polynucleotides in diagnostic assays;genetic engineering; identifying agonists and antagonists; conditions having PHPIP-180 imbalance; cardiovascular diseases; nervous system disorders; antitumor, - carcinogenic agents |
10/07/2008 | US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent |
10/07/2008 | US7432077 High-affinity choline transporter |
10/07/2008 | US7432053 Fluorescent protein from Aequorea coerulscens and methods for using the same |
10/07/2008 | US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |
10/07/2008 | CA2237296C Process for the preparation of peptides by way of streptavidin fusion proteins |
10/07/2008 | CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof |
10/07/2008 | CA2209426C Human pak65 |
10/07/2008 | CA2149319C Haemophilus outer membrane protein |
10/07/2008 | CA2087494C Soluble ldl receptor, its production and use |
10/02/2008 | WO2008118849A2 Hiv-1 protease inhibitors |
10/02/2008 | WO2008118093A1 Fusion protein capable of degrading amyloid beta peptide |
10/02/2008 | WO2008117792A1 Fluorescent labeled fused protein for assaying adenosine triphosphate |
10/02/2008 | WO2008116648A2 Novel glp-1 fusion peptides, their production and use |
10/02/2008 | WO2008116299A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3. |
10/02/2008 | WO2008116262A1 Methods and compositions for treating prostate cancer |
10/02/2008 | WO2007016591A3 Compositions and methods for monitoring and altering protein folding and solubility |
10/02/2008 | US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders |
10/02/2008 | US20080242839 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders |
10/02/2008 | US20080242624 Cyclin D Polynucleotides, Polypeptides and Uses Thereof |
10/02/2008 | US20080242590 New Method 706 |
10/02/2008 | US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
10/02/2008 | US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
10/02/2008 | US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
10/02/2008 | US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders |
10/02/2008 | US20080241116 Using vector comprising nucleotide sequences coding serine phage intergrase to transfer heterologous nucleotide sequences into cells; inproving exogenous gene expression; gene therapy |
10/02/2008 | CA2717659A1 Therapeutic applications of activation of human antigen-presenting cells through dectin-1 |
10/02/2008 | CA2681917A1 Methods and compositions for treating prostate cancer |
10/02/2008 | CA2681718A1 Hiv-1 protease inhibitors |
10/02/2008 | CA2681404A1 Fusion protein capable of degrading amyloid beta peptide |
10/02/2008 | CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3. |
10/02/2008 | CA2680837A1 Mek ligands and polynucleotides encoding mek ligands |
10/02/2008 | CA2653967A1 Lyase enzymes, nucleic acids encoding them and methods for making and using them |
10/01/2008 | EP1975620A2 Three hybrid assay system |
10/01/2008 | EP1975176A1 Novel glp-1 fusion peptides, their production and use |
10/01/2008 | EP1974752A1 Subcellular targeting of therapeutic proteins |
10/01/2008 | EP1974750A1 Preventive or therapeutic agent and method for immune disease |
10/01/2008 | EP1974749A1 Cripto blocking antibodies and uses thereof |
10/01/2008 | EP1974034A1 Polypeptide targeting to mitochondria |
10/01/2008 | EP1973953A2 Compositions and methods for treating obesity and related metabolic disorders |
10/01/2008 | EP1866340A4 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
10/01/2008 | CN101275147A Expression vector and fused protein of human differential initiator 3 and preparation thereof |
10/01/2008 | CN101274960A Genes associated with leishmania parasite virulence |
10/01/2008 | CN100422332C Expression and export of angiostation and endostatin as immunofusins |
10/01/2008 | CN100422210C Recombinant protective protein from streptococcus pneumoniae |
10/01/2008 | CN100422209C Sea snail toxin variant polypeptide compound, its preparation process and application thereof |
10/01/2008 | CN100421730C Immunogenic composition |
10/01/2008 | CA2654894A1 Csf3r polypeptides and uses thereof |
09/30/2008 | US7430476 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
09/30/2008 | US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease |
09/30/2008 | US7429645 Humanized anti-lymphotoxin beta receptor antibodies |
09/30/2008 | US7429644 Comprises lymphotoxin beta receptor (LT-BETA-R) immunoglobulin for treatment of tumor disorders |
09/30/2008 | US7429643 POSH nucleic acids, polypeptides and related methods |
09/30/2008 | US7429384 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis |
09/30/2008 | US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies |
09/25/2008 | WO2008114733A1 Anti-claudin-4 antibody |
09/25/2008 | WO2008113601A1 Glp-1 fusion peptides conjugated to polymer(s), their production and use |
09/25/2008 | WO2008077397A3 Method and means for concentrating, removing, and detecting gram-positive bacteria |
09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
09/25/2008 | US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue |
09/25/2008 | US20080233629 Fusion protein for use in genration of preferential biopolymers in plants |
09/25/2008 | US20080233609 Spirolactam Targeting Compounds and Related Compounds |
09/25/2008 | US20080233596 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
09/25/2008 | US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
09/25/2008 | CA2680708A1 Metal-binding therapeutic peptides |
09/24/2008 | EP1972689A2 A mutated immunoglobulin-binding protein |
09/24/2008 | EP1972349A1 GLP-1 fusion peptides conjugated to polymer(s), their production and use |
09/24/2008 | EP1971684A1 Chimaeric fusion protein with superior chaperone and folding activities |
09/24/2008 | EP1368476B1 Rearranged squamous cell carcinoma antigen genes ii |
09/24/2008 | EP1029046B1 Wnt-1 inducible genes |
09/24/2008 | CN101273134A Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes |
09/24/2008 | CN101273058A GLP-1 ( glucagon-like peptide-1 ) fusion polypeptides with increased peptidase resistance |
09/24/2008 | CN101270163A Single-chain fragment antibody-polypeptide amalgamation protein and uses thereof |
09/23/2008 | US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
09/23/2008 | US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
09/23/2008 | CA2294598C Transcriptional activators with graded transactivation potential |
09/23/2008 | CA2187283C Circularly permuted ligands and circularly permuted chimeric molecules |
09/18/2008 | WO2008110653A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof |